Treatment-resistant psychosis due to interaction between ritonavir and olanzapine : case report and literature review

Patients with schizophrenia are eight times more likely than healthy individuals to become infected with the human immunodeficiency virus (hiv). Although in vitro studies provide some data on the interaction between antipsychotics and retroviral agents, there is a lack of in vitro data on this subject. We describe the case of a 35-year-old patient who suffered from schizophrenia, polydrug abuse and an hiv infection and who also had treatment-resistant psychosis. An interaction between the antiretroviral drug ritonavir and the antipsychotic olanzapine turned out to be the cause of the treatment resistance. As far as we know, this is the first report of such a clinically relevant interaction. We present a review of the current literature on this type of interaction.

Medienart:

Artikel

Erscheinungsjahr:

2016

Erschienen:

2016

Enthalten in:

Zur Gesamtaufnahme - volume:58

Enthalten in:

Tijdschrift voor psychiatrie - 58(2016), 4 vom: 13., Seite 309-13

Sprache:

Niederländisch

Weiterer Titel:

Therapieresistente psychose door interactie tussen ritonavir en olanzapine

Beteiligte Personen:

van Oeffelt, Th [VerfasserIn]
Prinsen, E J D [VerfasserIn]

Themen:

12794-10-4
Anti-Retroviral Agents
Antipsychotic Agents
Benzodiazepines
Case Reports
Journal Article
N7U69T4SZR
O3J8G9O825
Olanzapine
Review
Ritonavir

Anmerkungen:

Date Completed 11.10.2016

Date Revised 02.12.2018

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM259373540